Femasys (NASDAQ:FEMY) Trading Up 3.6% – Still a Buy?

Femasys Inc. (NASDAQ:FEMY) shares rose 3.6% during trading on Wednesday . The stock traded as high as $0.57 and last traded at $0.5646. Approximately 237,616 shares traded hands during trading, a decline of 50% from the average daily volume of 474,095 shares. The stock had previously closed at $0.5450.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on FEMY. Wall Street Zen downgraded Femasys from a “hold” rating to a “sell” rating in a research report on Saturday, December 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Femasys in a report on Thursday, January 22nd. Finally, Laidlaw initiated coverage on shares of Femasys in a research note on Thursday, November 20th. They issued a “buy” rating and a $6.50 price objective on the stock. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $6.83.

Femasys Price Performance

The stock has a market capitalization of $33.02 million, a P/E ratio of -0.78 and a beta of -2.54. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.61 and a current ratio of 1.16. The business has a fifty day simple moving average of $0.60 and a 200-day simple moving average of $0.63.

Hedge Funds Weigh In On Femasys

Several institutional investors have recently made changes to their positions in FEMY. Geode Capital Management LLC boosted its position in shares of Femasys by 50.8% during the 4th quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock worth $224,000 after purchasing an additional 131,052 shares in the last quarter. Banco BTG Pactual S.A. acquired a new position in Femasys during the 4th quarter worth approximately $88,000. Jane Street Group LLC bought a new position in Femasys in the fourth quarter worth approximately $62,000. State Street Corp grew its stake in Femasys by 43.5% in the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock valued at $47,000 after acquiring an additional 24,500 shares during the period. Finally, Cetera Investment Advisers acquired a new stake in Femasys in the fourth quarter valued at approximately $36,000. Institutional investors and hedge funds own 65.27% of the company’s stock.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.